It is the cache of http://www.dovepress.com/clinical-features-and-treatment-of-maturity-onset-diabetes-of-the-youn-a9796. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Clinical features and treatment of maturity onset diabetes of the youn
skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

14804

Clinical features and treatment of maturity onset diabetes of the young (MODY)



Review

(7239) Total Article Views


Authors: Gardner DS,Tai ES

Published Date May 2012 Volume 2012:5 Pages 101 - 108
DOI: http://dx.doi.org/10.2147/DMSO.S23353

Daphne SL Gardner1, E Shyong Tai2
1Department of Endocrinology, Singapore General Hospital, 2Department of Endocrinology, National University Hospital, Singapore

Abstract: Maturity onset diabetes of the young (MODY) is a heterogeneous group of disorders that result in ß-cell dysfunction. It is rare, accounting for just 1%–2% of all diabetes. It is often misdiagnosed as type 1 or type 2 diabetes, as it is often difficult to distinguish MODY from these two forms. However, diagnosis allows appropriate individualized care, depending on the genetic etiology, and allows prognostication in family members. In this review, we discuss features of the common causes of MODY, as well as the treatment and diagnosis of MODY.

Keywords: type 1 diabetes, type 2 diabetes, HNF1A, HNF4A, HNF1B, GCK



Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter


Readers of this article also read:

  • ACC 2014

    We will attend the 2014 American College of Cardiology Scientific Session and Expo (ACC) on March 29-31, 2014. Stop by booth 3217 to talk with us.

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, University of Texas Health Science Center, San Antonio.